Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Shares Outstanding (Diluted Average) (2021 - 2023)

Historic Shares Outstanding (Diluted Average) for Terns Pharmaceuticals (TERN) over the last 3 years, with Q3 2023 value amounting to $71.5 million.

  • Terns Pharmaceuticals' Shares Outstanding (Diluted Average) rose 8573.64% to $71.5 million in Q3 2023 from the same period last year, while for Sep 2023 it was $71.5 million, marking a year-over-year increase of 8573.64%. This contributed to the annual value of $36.0 million for FY2022, which is 5869.43% up from last year.
  • As of Q3 2023, Terns Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $71.5 million, which was up 8573.64% from $71.4 million recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Shares Outstanding (Diluted Average) peaked at $71.5 million during Q3 2023, and registered a low of $22.7 million during Q4 2021.
  • Its 3-year average for Shares Outstanding (Diluted Average) is $42.8 million, with a median of $36.0 million in 2022.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first skyrocketed by 5313.8% in 2022, then soared by 18202.38% in 2023.
  • Over the past 3 years, Terns Pharmaceuticals' Shares Outstanding (Diluted Average) (Quarter) stood at $22.7 million in 2021, then soared by 58.69% to $36.0 million in 2022, then surged by 98.51% to $71.5 million in 2023.
  • Its Shares Outstanding (Diluted Average) stands at $71.5 million for Q3 2023, versus $71.4 million for Q2 2023 and $69.8 million for Q1 2023.